Abstract
The country Bosnia and Herzegovina (B&H) does not have a long tradition in pharmacovigilance, but the people in B&H have a long tradition of using herbal and traditional medicines (HTMs) for treating various diseases. Most HTMs are used by the rural population, and preparations are not registered with the medicines’ authorities. Due to traditional beliefs, costs, poor infrastructure, and difficult access to mainstream healthcare, rural populations in B&H are more likely to use HTMs than conventional medicines. HTMs are mostly used to treat diseases of the gastrointestinal tract and metabolism, and of the nervous and respiratory systems. From 2017 to 2019, the Agency for Medicines and Medical Devices of Bosnia and Herzegovina (ALMBIH) registered only five adverse drug reactions (ADRs) related to the use of HTMs. All these ADRs were non-serious and were known reactions for these HTMs. HTM products and preparations are not entirely safe and they should be used, as should other medicines, in cooperation with health professionals.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
The Agency for Medicinal Products and Medical Devices Bosnia and Herzegovina. Act on Medicines and Medical Devices (Official Gazette of B&H, No. 58/08)
The European Parliament and the Council of the European Union (2004) Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use. Off J Eur Union L136:85–90
Stabilisation and Association Agreement between the European Communities and Bosnia and Herzegovina. Decision (EU, Euratom) 2015/998 concluding the Stabilisation and Association Agreement between the European Communities and Bosnia and Herzegovina
Expert Council of the Agency for Medicinal Products and Medical Devices (2012) Rulebook on the manner of reporting, collecting and monitoring of adverse drug reactions (Official Gazette of B&H, No. 58/12)
Kondža M, Tubić B (2018) Report on adverse reactions to drugs and medical devices in Bosnia and Herzegovina for the year 2017. Agency for Medicines and Medical Devices of Bosnia and Herzegovina, Mostar
Kondža M, Tubić B (2019) Report on adverse reactions to drugs and medical devices in Bosnia and Herzegovina for the year 2018. Agency for Medicines and Medical Devices of Bosnia and Herzegovina, Mostar
European Medicines Agency (1995) Validation of analytical procedures: methodology (CHMP/ICH/281/95)
Kujundžić N (2014) Great folk-medicine book of Sinj. Croatian Academy of Science and Arts, Faculty of Pharmacy and Biochemistry, Matica hrvatska, Zagreb, p 756
Šarić-Kundalić B, Fritz E, Dobeš C, Saukel J (2010) Traditional medicine in the pristine village of Prokoško lake on Vranica mountain, Bosnia and Herzegovina. Sci Pharm 78(2):275–290. https://doi.org/10.3797/scipharm.1003-06
Pieroni A, Giusti ME, Quave CL (2011) Cross-cultural ethnobiology in the western Balkans: medical ethnobotany and ethnozoology among Albanians and Serbs in the Pešter plateau, Sandžak, South-Western Serbia. Hum Ecol 39(3):333–349
Lumpert M, Kreft S (2017) Folk use of medicinal plants in Karst and Gorjanci, Slovenia. J Ethnobiol Ethnomed 13:16
Žuna Pfeiffer T, Krstin LJ, Špoljarić Manorić D et al (2019) An ethnobotanical survey of useful wild plants in the north-eastern part of Croatia (Pannonian region). Plant Biosyst 154(4):463–473. https://doi.org/10.1080/11263504.2019.1635222
Crno tržište:Rupu u zakonu popunili lažni preparati. https://startbih.ba/clanak/crno-trzisterupu-u-zakonu-popunili-lazni-preparati/116641. Accessed 11 May 2020
Glamočlija U, Tubić B, Kondža M, Zolak A, Grubiša N (2018) Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study. Croat Med J 59(3):124–131
Kondža M, Tubić B (2018) The role of the pharmacist in reporting adverse drug reactions. XX simpozijum farmaceuta Republike Srpske s međunarodnim učešćem
Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. Off J Eur Union 136/1
Agency for Medicines and Medical Devices of Montenegro (2017) Izvještaj o rezultatima prijavljivanja neželjenih dejstava ljekova za 2016. godinu
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kondža, M., Tubić, B. (2022). Pharmacovigilance for Herbal and Traditional Medicines in Bosnia and Herzegovina. In: Barnes, J. (eds) Pharmacovigilance for Herbal and Traditional Medicines. Adis, Cham. https://doi.org/10.1007/978-3-031-07275-8_18
Download citation
DOI: https://doi.org/10.1007/978-3-031-07275-8_18
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-031-07273-4
Online ISBN: 978-3-031-07275-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)